Live Breaking News & Updates on Lukej Burchill

SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations. ....

United States , University Medical Center , Anastasiad Egorova , Lukej Burchill , Journal Of The American College Cardiology , European Society Of Cardiology , Department Of Cardiovascular Medicine , Leiden University Medical Center , American College , European Society , Cardiovascular Medicine , Mayo Clinic , Heart Failure , Sglt2 Inhibitors , Odium Glucose Transporter 2 Inhibitors , Odium Glucose Co Transporter 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Ype 2 Dm , Congenital Heart Disease , Adverse Effects , Side Effects , Patient Safety , Skin And Soft Tissue Infection ,